<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30275645</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Print">0300-0508</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>70</Volume>                    <Issue>3</Issue>                    <PubDate>                        <Year>2018</Year>                        <Season>Summer</Season>                    </PubDate>                </JournalIssue>                <Title>Physiotherapy Canada. Physiotherapie Canada</Title>                <ISOAbbreviation>Physiother Can</ISOAbbreviation>            </Journal>            <ArticleTitle>Self-Management Strategies for Malignant Lymphedema: A Case Report with 1-Year and 4-Year Follow-Up Data.</ArticleTitle>            <Pagination>                <MedlinePgn>204-211</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.3138/ptc.2016-94</ELocationID>            <Abstract>                <AbstractText><b>                        <i>Purpose:</i>                    </b> Malignant lymphedema is an accumulation of interstitial fluid caused by tumour infiltration or compression of lymphatic vessels. Our objective is to describe self-management strategies for malignant lymphedema using a case report. <b>                        <i>Client Description:</i>                    </b> A 50-year-old woman with advanced breast cancer was referred to our centre with a 3-month history of unexplained left-arm edema, subsequently diagnosed as malignant lymphedema caused by tumour compression of the axillary lymph nodes. <b>                        <i>Intervention:</i>                    </b> She undertook a physiotherapist-guided, modified lymphedema treatment programme, with self-management interventions including self-bandaging and exercise. Limb volumes and leisure exercise levels were measured over a 1-year period. Data were collected from her follow-up visit 4 years post-diagnosis of lymphedema. <b>                        <i>Measures and Outcome:</i>                    </b> Within the first month, the patient's excess limb volume reduced from 26.8% to 5.9% and, 1 year later, remained stable at 3%. Over time, her exercise levels increased (1-year follow-up: 33.5 MET-hours per week). At 4 years, her excess limb volume was 9.7%, and exercise levels were at 36 MET-hours per week. <b>                        <i>Implications:</i>                    </b> A woman with moderate malignant arm lymphedema caused by advanced breast cancer successfully adhered to a guided self-management programme and benefited from reduced swelling and improved self-reported physical function in the long term. This case provides oncology health professionals with knowledge about self-management options for malignant lymphedema.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Shallwani</LastName>                    <ForeName>Shirin M</ForeName>                    <Initials>SM</Initials>                    <AffiliationInfo>                        <Affiliation>Lymphedema Program.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Physiotherapy Department, McGill University Health Centre.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, McGill University, Montreal.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Towers</LastName>                    <ForeName>Anna</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Lymphedema Program.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>School of Rehabilitation Sciences, University of Ottawa, Ottawa.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>Canada</Country>            <MedlineTA>Physiother Can</MedlineTA>            <NlmUniqueID>0346574</NlmUniqueID>            <ISSNLinking>0300-0508</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>J Cancer Educ. 2011 Mar;26(1):12-21</RefSource>                <PMID Version="1">21161465</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2007 Mar;101(3):285-90</RefSource>                <PMID Version="1">16826318</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Rehabil Med. 2013 Jun;37(3):396-402</RefSource>                <PMID Version="1">23869338</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2001 Jan 17;93(2):96-111</RefSource>                <PMID Version="1">11208879</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cancer Surviv. 2013 Mar;7(1):83-92</RefSource>                <PMID Version="1">23212603</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Support Care Cancer. 2016 Jan;24(1):139-46</RefSource>                <PMID Version="1">25957012</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Can Fam Physician. 2010 Dec;56(12):1277-84</RefSource>                <PMID Version="1">21375063</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Support Care Cancer. 2011 May;19(5):631-7</RefSource>                <PMID Version="1">20393753</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Hosp Palliat Care. 2014 Feb;31(1):38-44</RefSource>                <PMID Version="1">23423772</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2013 May;14(6):500-15</RefSource>                <PMID Version="1">23540561</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Physiother Can. 2014 Fall;66(4):404-12</RefSource>                <PMID Version="1">25922562</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PM R. 2012 Aug;4(8):580-601</RefSource>                <PMID Version="1">22920313</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2007 Apr;18(4):639-46</RefSource>                <PMID Version="1">17018707</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Phys Ther. 2006 Feb;86(2):205-14</RefSource>                <PMID Version="1">16445334</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Sci Sports Exerc. 2011 Aug;43(8):1575-81</RefSource>                <PMID Version="1">21681120</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Patient Educ Couns. 2002 Oct -Nov;48(2):177-87</RefSource>                <PMID Version="1">12401421</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2001 Aug 15;92(4 Suppl):980-7</RefSource>                <PMID Version="1">11519024</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2011 Mar 15;117(6):1136-48</RefSource>                <PMID Version="1">21381006</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>QJM. 2003 Oct;96(10):731-8</RefSource>                <PMID Version="1">14500859</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Semin Oncol Nurs. 2013 Feb;29(1):28-40</RefSource>                <PMID Version="1">23375064</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Phys Med Rehabil. 2013 Mar;92(3):223-31</RefSource>                <PMID Version="1">23069748</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2015 Jun;151(2):393-403</RefSource>                <PMID Version="1">25940996</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Support Care Cancer. 2014 Jan;22(1):135-43</RefSource>                <PMID Version="1">24013569</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nurs Res. 2012 Jul-Aug;61(4):291-9</RefSource>                <PMID Version="1">22565103</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2843-60</RefSource>                <PMID Version="1">9874410</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <OtherAbstract Type="Publisher" Language="fre">            <AbstractText><b>                    <i>Objectif :</i>                </b> le lymphœdème malin désigne une accumulation de liquide interstitiel causé par l'infiltration d'une tumeur ou la compression des vaisseaux lymphatiques. Les auteurs utilisent un rapport de cas pour décrire des stratégies d'autogestion du lymphœdème malin. <b>                    <i>Description de la cliente :</i>                </b> une femme de 50 ans atteinte d'un cancer du sein avancé a été dirigée vers le centre des auteurs parce qu'elle présentait un œdème inexpliqué du bras gauche depuis trois mois. Cet œdème a ensuite été diagnostiqué comme un lymphœdème causé par la compression d'une tumeur sur les ganglions axillaires. <b>                    <i>Intervention :</i>                </b> la patiente a entrepris un traitement modifié du lymphœdème, orienté par des physiothérapeutes et comportant des interventions d'autogestion, y compris les changements de bandages et des exercices. Les auteurs ont mesuré le volume des membres et le taux d'exercices de loisir sur une période d'un an. Ils ont recueilli les données jusqu'au rendez-vous de suivi quatre ans après le diagnostic de lymphœdème. <b>                    <i>Mesures et résultats :</i>                </b> au cours du premier mois, le volume excédentaire du membre de la patiente est passé de 26,8 % à 5,9 % et était demeuré stable un an plus tard, à 3 %. Au fil du temps le taux d'exercice de la patiente a augmenté (suivi d'un an : 33,5 équivalents métaboliques de l'effort [MET]-heures par semaine). Au bout de quatre ans, le volume excédentaire de son bras était de 9,7 %, et son taux d'exercice, de 36 MET-heures par semaine. <b>                    <i>Conséquences :</i>                </b> une femme présentant un lymphœdème malin modéré du bras causé par un cancer du sein avancé a suivi un programme d'autogestion orienté et observé une diminution de son œdème et une amélioration autodéclarée de sa fonction physique à long terme. Ce cas fournit aux professionnels en oncologie de des connaissances sur les possibilités d'autogestion du lymphœdème malin.</AbstractText>        </OtherAbstract>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">exercise</Keyword>            <Keyword MajorTopicYN="N">lymphedema</Keyword>            <Keyword MajorTopicYN="N">self-care</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pmc-release">                <Year>2019</Year>                <Month>08</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30275645</ArticleId>            <ArticleId IdType="doi">10.3138/ptc.2016-94</ArticleId>            <ArticleId IdType="pii">ptc.2016-94</ArticleId>            <ArticleId IdType="pmc">PMC6158562</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>